Conference: Let’s talk about neurocognitive disorders

The City of Hudson and the Hudson Senior Citizens Committee, in partnership with McGill University’s Neurocognitive Disorders Education Program, will host a Let’s Talk Neurocognitive Disorders conference at the Stephen F. Shaar Community Center on Wednesday, May 15 at 7:00 p.m.

The purpose of this public lecture is to raise awareness and provide basic information about Alzheimer’s disease and other diseases associated with neurocognitive disorders.

During the presentation, Dr. Serge Gauthier, clinical neurologist, will provide information on the different types of neurocognitive disorders. He will discuss the associated symptoms that appear as the disease progresses and explain how they may differ from typical problems associated with aging.

Next, he shares practical tips on how to care for someone with a neurocognitive disorder. It will address important issues related to ensuring the safety and well-being of the individual and their care partner, and helping families understand and access the resources needed to cope with this disease.

A question and answer period will follow.

Dr. Serge Gauthier is a clinical neurologist who specializes in developing new diagnostic and treatment tools for people with Alzheimer’s disease.

Dr. Gauthier was a clinical investigator and neurologist at the Montreal Neurological Institute and Hospital (1976–1986), Director of the McGill Center for Research on Aging (1986–1996), and Director of the Research Unit for Alzheimer’s Disease and Related Disorders at the Center for Research and Study on Aging from 1997 to 2021 year. From 1997 to 2007, he was a senior scientist in the CIHR (Canadian Institutes of Health Research) research and development program.

In research, he has made significant contributions to the design and conduct of randomized clinical trials aimed at establishing the safety and efficacy of cholinesterase inhibitors, muscarinic agonists, and agents capable of modifying the progression of Alzheimer’s disease and vascular dementia.

He is particularly interested in consensus approaches to the treatment of dementia at different stages, the ethics of research involving people with dementia, and strategies for early prevention of cognitive decline and dementia.

The conference is free and open to everyone. No registration required.